{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:49:43Z","timestamp":1775058583567,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T00:00:00Z","timestamp":1468886400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00392-016-1021-x","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T03:52:37Z","timestamp":1468900357000},"page":"38-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation"],"prefix":"10.1007","volume":"106","author":[{"given":"Melanie","family":"Gunawardene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sch\u00e4ffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. \u00d6.","family":"Akbulak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jularic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Eickholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"N\u00fchrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kuklik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Czerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. A.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,19]]},"reference":[{"issue":"2","key":"1021_CR1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIRCEP.111.964916","volume":"5","author":"P Santangeli","year":"2012","unstructured":"Santangeli P, Di Biase L, Horton R, Burkhardt JD, Sanchez J, Al-Ahmad A et al (2012) Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications evidence from a meta-analysis. Circ Arrhythmia Electrophysiol 5(2):302\u2013311","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"1021_CR2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijcard.2015.03.376","volume":"187","author":"R Nairooz","year":"2015","unstructured":"Nairooz R, Sardar P, Payne J, Aronow WS, Paydak H (2015) Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation. Int J Cardiol 187:426\u2013429","journal-title":"Int J Cardiol"},{"issue":"16","key":"1021_CR3","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1161\/CIRCULATIONAHA.113.005376","volume":"129","author":"JI Weitz","year":"2014","unstructured":"Weitz JI, Healey JS, Skanes AC, Verma A (2014) Periprocedural management of new oral anticoagulants in patients undergoing atrial fibrillation ablation. Circulation 129(16):1688\u20131694","journal-title":"Circulation"},{"issue":"3","key":"1021_CR4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/CIRCEP.113.000320","volume":"6","author":"M Bassiouny","year":"2013","unstructured":"Bassiouny M, Saliba W, Rickard J, Shao M, Sey A, Diab M et al (2013) Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Circ Arrhythmia Electrophysiol 6(3):460\u2013464","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"4","key":"1021_CR5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.hrthm.2012.12.011","volume":"10","author":"J-S Kim","year":"2013","unstructured":"Kim J-S, She F, Jongnarangsin K, Chugh A, Latchamsetty R, Ghanbari H et al (2013) Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm 10(4):483\u2013489","journal-title":"Heart Rhythm"},{"issue":"1","key":"1021_CR6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2014.10.005","volume":"115","author":"B Kaess","year":"2015","unstructured":"Kaess B, Ammar S, Reents T, Dillier R, Lennerz C, Semmler V et al (2015) Comparison of safety of left atrial catheter ablation procedures for atrial arrhythmias under continuous anticoagulation with apixaban versus phenprocoumon. Am J Cardiol 115(1):47\u201351","journal-title":"Am J Cardiol"},{"key":"1021_CR7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.ijcard.2015.11.085","volume":"203","author":"J Garg","year":"2016","unstructured":"Garg J, Chaudhary R, Krishnamoorthy P, Shah N, Natale A, Bozorgnia B (2016) Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: a metaanalysis of 1362 patients. Int J Cardiol 203:906\u2013908","journal-title":"Int J Cardiol"},{"issue":"10","key":"1021_CR8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2169\/internalmedicine.54.3520","volume":"54","author":"T Nagao","year":"2015","unstructured":"Nagao T, Inden Y, Shimano M, Fujita M, Yanagisawa S, Kato H et al (2015) Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation. Intern Med 54(10):1167\u20131173","journal-title":"Intern Med"},{"issue":"10","key":"1021_CR9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2013.11.039","volume":"63","author":"D Lakkireddy","year":"2014","unstructured":"Lakkireddy D, Reddy YM, Di Biase L, Vallakati A, Mansour MC, Santangeli P et al (2014) Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol 63(10):982\u2013988","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1021_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00392-013-0616-8","volume":"103","author":"S Ewen","year":"2014","unstructured":"Ewen S, Rettig-Ewen V, Mahfoud F, B\u00f6hm M, Laufs U (2014) Drug adherence in patients taking oral anticoagulation therapy. Clin Res Cardiol 103(3):173\u2013182","journal-title":"Clin Res Cardiol"},{"key":"1021_CR11","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.hrthm.2015.02.028","volume":"12","author":"L Biase Di","year":"2015","unstructured":"Di Biase L, Lakkireddy D, Trivedi C, Denke T, Martinek M, Mohanty S (2015) Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study. Hear Rhythm 12:1162\u20131168","journal-title":"Hear Rhythm"},{"issue":"10","key":"1021_CR12","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/europace\/euu196","volume":"16","author":"RA Winkle","year":"2014","unstructured":"Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA (2014) Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban. Europace 16(10):1443\u20131449","journal-title":"Europace"},{"issue":"13","key":"1021_CR13","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.112.105221","volume":"126","author":"D Siegal","year":"2012","unstructured":"Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC (2012) Periprocedural heparin bridging in patients receiving Vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 126(13):1630\u20131639","journal-title":"Circulation"},{"issue":"2","key":"1021_CR14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIRCEP.112.000143","volume":"6","author":"J-S Kim","year":"2013","unstructured":"Kim J-S, Jongnarangsin K, Latchamsetty R, Chugh A, Ghanbari H, Crawford T et al (2013) The optimal range of international normalized ratio for radiofrequency catheter ablation of atrial fibrillation during therapeutic anticoagulation with warfarin. Circ Arrhythmia Electrophysiol 6(2):302\u2013309","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"24","key":"1021_CR15","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.jacc.2015.09.088","volume":"66","author":"J Vogler","year":"2015","unstructured":"Vogler J, Willems S, Sultan A, Schreiber D, L\u00fcker J, Servatius H et al (2015) Pulmonary vein isolation versus defragmentation. J Am Coll Cardiol 66(24):2743\u20132752","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1021_CR16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/CIRCEP.114.001672","volume":"8","author":"D Schreiber","year":"2015","unstructured":"Schreiber D, Rostock T, Frohlich M, Sultan A, Servatius H, Hoffmann BA et al (2015) Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success. Circ Arrhythm Electrophysiol 8(2):308\u2013317","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"1021_CR17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jce.12319","volume":"25","author":"BA Hoffmann","year":"2014","unstructured":"Hoffmann BA, Kuck K-H, Andresen D, Spitzer SG, Hoffmann E, Schumacher B et al (2014) Impact of structural heart disease on the acute complication rate in atrial fibrillation ablation: results from the German Ablation Registry. J Cardiovasc Electrophysiol 25(3):242\u2013249","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"1021_CR18","doi-asserted-by":"crossref","first-page":"654.e1","DOI":"10.1016\/j.amjmed.2014.11.035","volume":"128","author":"JC Hsu","year":"2015","unstructured":"Hsu JC, Chan PS, Tang F, Maddox TM, Marcus GM (2015) Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation. Am J Med 128(6):654.e1\u2013654.e10","journal-title":"Am J Med"},{"issue":"5","key":"1021_CR19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/europace\/eut083","volume":"15","author":"H Heidbuchel","year":"2013","unstructured":"Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J et al (2013) European heart rhythm association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 15(5):625\u2013651","journal-title":"Europace"},{"issue":"3","key":"1021_CR20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/europace\/eur328","volume":"14","author":"TV Salukhe","year":"2012","unstructured":"Salukhe TV, Willems S, Drewitz I, Steven D, Hoffmann BA, Heitmann K et al (2012) Propofol sedation administered by cardiologists without assisted ventilation for long cardiac interventions: an assessment of 1000 consecutive patients undergoing atrial fibrillation ablation. Europace 14(3):325\u2013330","journal-title":"Europace"},{"issue":"2","key":"1021_CR21","doi-asserted-by":"crossref","first-page":"e003354","DOI":"10.1161\/CIRCEP.115.003354","volume":"9","author":"T Lankveld","year":"2016","unstructured":"Lankveld T, Zeemering S, Scherr D, Kuklik P, Hoffmann BA, Willems S et al (2016) Atrial fibrillation complexity parameters derived from surface ECGs predict procedural outcome and long-term follow-up of stepwise catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol 9(2):e003354","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"1021_CR22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.hrthm.2011.12.016","volume":"9","author":"H Calkins","year":"2012","unstructured":"Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen S-A et al (2012) 2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm 9(4):632\u2013696","journal-title":"Heart Rhythm"},{"issue":"25","key":"1021_CR23","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","volume":"129","author":"L Biase Di","year":"2014","unstructured":"Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R et al (2014) Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the role of Coumadin in preventing thromboembolism in atrial fibrillation (AF) patient. Circulation 129(25):2638\u20132644","journal-title":"Circulation"},{"key":"1021_CR24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1540-8159.2009.02604.x","volume":"33","author":"TJ Bunch","year":"2010","unstructured":"Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS et al (2010) Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin Electrophysiol 33:146\u2013152","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"1021_CR25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.hrthm.2014.09.049","volume":"12","author":"K Nademanee","year":"2015","unstructured":"Nademanee K, Amnueypol M, Lee F, Drew CM, Suwannasri W, Schwab MC et al (2015) Benefits and risks of catheter ablation in elderly patients with atrial fibrillation. Heart Rhythm 12(1):44\u201351","journal-title":"Heart Rhythm"},{"issue":"6","key":"1021_CR26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1540-8167.2008.01181.x","volume":"19","author":"DD Spragg","year":"2008","unstructured":"Spragg DD, Dalal D, Cheema A, Scherr D, Chilukuri K, Cheng A et al (2008) Complications of catheter ablation for atrial fibrillation: incidence and predictors. J Cardiovasc Electrophysiol 19(6):627\u2013631","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"1021_CR27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00392-014-0804-1","volume":"104","author":"JM N\u00fchrich","year":"2015","unstructured":"N\u00fchrich JM, Kuck KH, Andresen D, Steven D, Spitzer SG, Hoffmann E et al (2015) Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry. Clin Res Cardiol 104(6):463\u2013470","journal-title":"Clin Res Cardiol"},{"issue":"7","key":"1021_CR28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00392-015-0823-6","volume":"104","author":"J Kornej","year":"2015","unstructured":"Kornej J, Kosiuk J, Hindricks G, Arya A, Sommer P, Rolf S et al (2015) Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Clin Res Cardiol 104(7):603\u2013610","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"1021_CR29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jce.12856","volume":"27","author":"A Rillig","year":"2016","unstructured":"Rillig A, Lin T, Plesman J, Heeger C-H, Lemes C, Metzner A et al (2016) Apixaban, rivaroxaban and dabigatran in patients undergoing atrial fibrillation ablation. J Cardiovasc Electrophysiol 27(2):147\u2013153","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"1021_CR30","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","volume":"17","author":"H Heidbuchel","year":"2015","unstructured":"Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W et al (2015) Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17(10):1467\u20131507","journal-title":"Europace"},{"issue":"9","key":"1021_CR31","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.hrthm.2015.04.016","volume":"12","author":"T Nagao","year":"2015","unstructured":"Nagao T, Inden Y, Yanagisawa S, Kato H, Ishikawa S, Okumura S et al (2015) Differences in the activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation. Heart Rhythm 12(9):1972\u20131978","journal-title":"Heart Rhythm"},{"issue":"2","key":"1021_CR32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10840-015-0048-7","volume":"44","author":"A Bin Abdulhak","year":"2015","unstructured":"Bin Abdulhak A, Kennedy K, Gupta S, Giocondo M, Ramza B, Wimmer A (2015) Effect of pre-procedural interrupted apixaban on heparin anticoagulation during catheter ablation for atrial fibrillation: a prospective observational study. J Cardiovasc Electrophysiol 44(2):91\u201396","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-016-1021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-016-1021-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-016-1021-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-016-1021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T14:42:32Z","timestamp":1498315352000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-016-1021-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,19]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1007\/s00392-016-1021-x","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,19]]}}}